Corton Capital’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $570K | Buy |
+14,424
| New | +$570K | 0.66% | 8 |
|
|
2024
Q2 | – | Sell |
-10,631
| Closed | -$461K | – | 619 |
|
|
2024
Q1 | $461K | Sell |
10,631
-845
| -7% | -$36.6K | 0.17% | 155 |
|
|
2023
Q4 | $581K | Buy |
11,476
+2,581
| +29% | +$131K | 0.18% | 136 |
|
|
2023
Q3 | $403K | Buy |
8,895
+1,966
| +28% | +$89.2K | 0.2% | 139 |
|
|
2023
Q2 | $284K | Sell |
6,929
-2,111
| -23% | -$86.6K | 0.13% | 228 |
|
|
2023
Q1 | $323K | Sell |
9,040
-3,598
| -28% | -$129K | 0.22% | 131 |
|
|
2022
Q4 | $477K | Buy |
12,638
+3,215
| +34% | +$121K | 0.39% | 64 |
|
|
2022
Q3 | $417K | Buy |
9,423
+1,025
| +12% | +$45.4K | 0.51% | 59 |
|
|
2022
Q2 | $311K | Sell |
8,398
-411
| -5% | -$15.2K | 0.29% | 139 |
|
|
2022
Q1 | $326K | Buy |
+8,809
| New | +$326K | 0.14% | 207 |
|